Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rasagiline in early Parkinson's disease (China, levodopa-naïve)
CTR20131836Phase 3Completed
- Sponsor
- Lingbei Biopharma
- Start
- Apr 2015
- Modality
- Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of rasagiline in Parkinson's disease (PD), sponsored by Lingbei Biopharma. Started Apr 2015; status: completed.
02
Drugs
rasagiline
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on CTR20131836.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20131836.